Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 1,001–1,100 of 1,133
Deneault, E., White, S. H., Rodrigues, D. C., Ross, P. J., Faheem, M., Zaslavsky, K., Wang, Z., Alexandrova, R., Pellecchia, G., Wei, W., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.003 · Cited by 145
“Alternatively, in a different approach, mature somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) that can grow indefinitely in vitro (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundLee, Y. T., de Vasconcellos, J. F., Yuan, J., Byrnes, C., Noh, S.-J., Meier, E. R., Kim, K. S., Rabel, A., Kaushal, M., Muljo, S. A., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472308 · Cited by 142
“LIN28 acts with other factors to induce the pluripotency of somatic cells.(19) During mammalian development, expression of LIN28 proteins is reduced after embryogenesis.”
BackgroundHigh-Throughput Discovery of Synthetic Surfaces That Support Proliferation of Pluripotent Cells
Derda, R., Musah, S., Orner, B. P., Klim, J. R., Li, L., & Kiessling, L. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja906089g · Cited by 144
Siu, C.-W., Lee, Y.-K., Ho, J. C.-Y., Lai, W.-H., Chan, Y.-C., Ng, K.-M., Wong, L.-Y., Au, K.-W., Lau, Y.-M., Zhang, J., et al. (2012) · Aging · doi:10.18632/aging.100503 · Cited by 141
“Latest breakthrough in the generation of human induced pluripotent stem cells (iPSC) from adult somatic tissues [19, 20] provides a unique opportunity to produce patient-specific cardiomyocytes for disease modeling and drug screening (21-23).”
BackgroundPoetsch, M. S., Strano, A., & Guan, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac020 · Cited by 144
“10 Currently, blood cells and skin fibroblasts are the most commonly used cell types for reprogramming because (1) they are easy to obtain, (2) conditions for the initial culture of these cells are well established, (3) reprogramming methods for these cells are successfully standardized, and (4) iPSC banking has been…”
BackgroundStem cell models of Alzheimer’s disease: progress and challenges
Arber, C., Lovejoy, C., & Wray, S. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0268-4 · Cited by 143
“In 2007, the exogenous introduction of a cocktail of pluripotency-associated transcription factors such as OCT4, KLF4, SOX2 and c-MYC into terminally differentiated cells such as fibroblasts was shown to be sufficient to revert them to a pluripotent state, indistinguishable from human embryonic stem cells (hESCs) [3,…”
Complex Tissue and Disease Modeling using hiPSCs
Passier, R., Orlova, V., & Mummery, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.011 · Cited by 142
“…based on primary cell cultures or transformed cell lines (Alonzo et al., 2015; Bertassoni et al., 2014; Bischel et al., 2013; Jeon et al., 2014; Kim et al., 2016; Moya et al., 2013; Nguyen et al., 2013; Sackmann et al., 2014; Wang et al., 2016; Zervantonakis et al., 2011, 2012; Zheng et al., 2012).”
BackgroundThe Information Theory of Aging
Lu, Y. R., Tian, X., & Sinclair, D. A. (2023) · Nature Aging · doi:10.1038/s43587-023-00527-6 · Cited by 141
“These iPSCs are notable, not only because they can be coaxed into numerous cell types, but also because they have an epigenetic age of zero and display rejuvenated characteristics 51,52 (Fig.”
Chemically induced reprogramming to reverse cellular aging
Yang, J.-H., Petty, C. A., Dixon-McDougall, T., Lopez, M. V., Tyshkovskiy, A., Maybury-Lewis, S., Tian, X., Ibrahim, N., Chen, Z., Griffin, P. T., et al. (2023) · Aging · doi:10.18632/aging.204896 · Cited by 136
“These findings initiated the field of cell reprogramming, with a string of publications in the 2000s showing that the identity of many different types of adult cells from different species could be erased to become induced pluripotent stem cells, commonly known as “iPSCs” [17, 19–21].”
BackgroundEmerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Nair, G. G., Tzanakakis, E. S., & Hebrok, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0375-3 · Cited by 134
Katt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152105 · Cited by 129
“IMR90-4 was induced from fetal fibroblasts using lentiviral vectors; DF6-9-9T and DF19-9-11T were both induced from foreskin fibroblasts using the oriP/EBNA-1 episomal vector [15, 16].”
MethodInduced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Panicker, L. M., Miller, D., Park, T. S., Patel, B., Azevedo, J. L., Awad, O., Masood, M. A., Veenstra, T. D., Goldin, E., Stubblefield, B. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207889109 · Cited by 129
“For GC enzymatic activity in cell lysates, cells were lysed as described (9).”
MethodStrategies and prospects of effective neural circuits reconstruction after spinal cord injury
Yang, B., Zhang, F., Cheng, F., Ying, L., Wang, C., Shi, K., Wang, J., Xia, K., Gong, Z., Huang, X., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2620-z · Cited by 128
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
Lin28 promotes the proliferative capacity of neural progenitor cells in brain development
Yang, M., Yang, S.-L., Herrlinger, S., Liang, C., Dzieciatkowska, M., Hansen, K. C., Desai, R., Nagy, A., Niswander, L., Moss, E. G., et al. (2015) · Development · doi:10.1242/dev.120543 · Cited by 127
“DISCUSSION Lin28a/b play essential roles in a variety of biological processes and diseases, including ESC self-renewal, iPSC formation, cancers and type II diabetes (Peng et al., 2011; Shyh-Chang and Daley, 2013; Thornton and Gregory, 2012; Yu et al., 2007).”
BackgroundBelair, D. G., Whisler, J. A., Valdez, J., Velazquez, J., Molenda, J. A., Vickerman, V., Lewis, R., Daigh, C., Hansen, T. D., Mann, D. A., et al. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9549-5 · Cited by 120
“Human pluripotent stem cells have received increasing attention for tissue modeling applications, as they provide a well-defined source of tissue-specific cell types[16–18].”
Self-citationLaterza, C., Merlini, A., De Feo, D., Ruffini, F., Menon, R., Onorati, M., Fredrickx, E., Muzio, L., Lombardo, A., Comi, G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3597 · Cited by 121
“Induced pluripotent stem cells (iPSCs)—a new source of pluripotent stem cells obtained by genetic reprogramming of somatic cells 9–11 — might represent the ideal autologous source of NPCs for transplantation and translational purposes in MS.”
Reprogramming the epigenome with vitamin C
Lee Chong, T., Ahearn, E. L., & Cimmino, L. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00128 · Cited by 120
“Vitamin C-treated mouse ESCs in culture change their distribution of H3K27me3 across the genome (Ebata et al., 2017), however, the effect on total levels were shown to be minor suggesting that modulation of Utx by vitamin C during Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 July 2019 | Volume 7…”
BackgroundInfluentialModeling psychiatric disorders at the cellular and network levels
Brennand, K. J., Simone, A., Tran, N., & Gage, F. H. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.20 · Cited by 119
Cell delivery therapeutics for musculoskeletal regeneration☆
Nöth, U., Rackwitz, L., Steinert, A. F., & Tuan, R. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.004 · Cited by 119
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells
Xue, Y., Qian, H., Hu, J., Zhou, B., Zhou, Y., Hu, X., Karakhanyan, A., Pang, Z., & Fu, X.-D. (2016) · Nature Neuroscience · doi:10.1038/nn.4297 · Cited by 118
Microengineered Liver Tissues for Drug Testing
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015) · SLAS Technology · doi:10.1177/2211068214566939 · Cited by 116
Human papillomavirus type 16 E7 oncoprotein associates with E2F6
McLaughlin-Drubin, M. E., Huh, K.-W., & Münger, K. (2008) · Journal of Virology · doi:10.1128/jvi.00579-08 · Cited by 116
“Recently, it was reported that normal diploid cells can be converted to stem cells via the alteration of the expression of genes that are usually epigenetically silenced (70, 85).”
BackgroundAn epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator
Lee, D.-S., Shin, J.-Y., Tonge, P. D., Puri, M. C., Lee, S., Park, H., Lee, W.-C., Hussein, S. M. I., Bleazard, T., Yun, J.-Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6619 · Cited by 113
Bardy, J., Chen, A. K., Lim, Y. M., Wu, S., Wei, S., Weiping, H., Chan, K., Reuveny, S., & Oh, S. K. W. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0146 · Cited by 111
“Serial expansion of iPS (IMR90) in static MC culture iPS (IMR90) cells derived from human fetal fibroblasts by Yu et al. , 2007, 3 can be propagated in 2D Matrigel-coated culture in an mTeSR1 serum-free defined medium.”
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
Yang, J., Hirai, Y., Iida, K., Ito, S., Trumm, M., Terada, S., Sakai, R., Tsuchiya, T., Tabata, O., & Kamei, K.-I. (2020) · doi:10.1101/2020.06.10.141606 · Cited by 110
Adult Stem Cells and Diseases of Aging
Boyette, L., & Tuan, R. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3010088 · Cited by 108
“epigenetic events, can direct terminally differentiated cells to revert to a state similar to that of an ESC [184,186–189], resulting in iPS cells that are pluripotent and germ-line competent, and exhibit the capacity for chimerism and teratoma formation and a gene expression profile characteristic of”
BackgroundHuman artificial chromosomes for gene delivery and the development of animal models
Kazuki, Y., & Oshimura, M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.136 · Cited by 108
Telomere Dynamics in Human Cells Reprogrammed to Pluripotency
Suhr, S. T., Chang, E. A., Rodriguez, R. M., Wang, K., Ross, P. J., Beyhan, Z., Murthy, S., & Cibelli, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008124 · Cited by 107
“…from human subjects of two age extremes – 16 weeks of gestation (line FIBA), and 70-years of age (line FIBB) – were converted to IPSCs by expression of reprogramming factor combinations described by Yu et al. (2007)[14] and Takahashi et al. (2007)[15] using lentiviral vectors shown in Figure 1.”
InfluentialFluri, D. A., Tonge, P. D., Song, H., Baptista, R. P., Shakiba, N., Shukla, S., Clarke, G., Nagy, A., & Zandstra, P. W. (2012) · Nature Methods · doi:10.1038/nmeth.1939 · Cited by 106
Faley, S. L., Neal, E. H., Wang, J. X., Bosworth, A. M., Weber, C. M., Balotin, K. M., Lippmann, E. S., & Bellan, L. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.009 · Cited by 106
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0620 · Cited by 105
“Early reprogramming constructs contained a single individual reprogramming gene on each plasmid, and, therefore, at least four integrations were necessary for successful reprogramming due to the use of four separate vectors [1,2].”
Backgroundlet-7 miRNAs Can Act through Notch to Regulate Human Gliogenesis
Patterson, M., Gaeta, X., Loo, K., Edwards, M., Smale, S., Cinkornpumin, J., Xie, Y., Listgarten, J., Azghadi, S., Douglass, S. M., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.08.015 · Cited by 103
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening
Eglen, R., & Reisine, T. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0305 · Cited by 100
Development of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Yildirim, Y., Naito, H., Didié, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., & Zimmermann, W.-H. (2007) · Circulation · doi:10.1161/circulationaha.106.679688 · Cited by 100
“Diesbezüglich konnten bereits beachtliche Fortschritte wie die Behandlung der Sichelzellenanemie im Mausmodell [32] und das Herstellen von humanen iPS [33-35] erbracht werden.”
BackgroundDiversity among POU transcription factors in chromatin recognition and cell fate reprogramming
Malik, V., Zimmer, D., & Jauch, R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2748-5 · Cited by 98
Yang, J., Hirai, Y., Iida, K., Ito, S., Trumm, M., Terada, S., Sakai, R., Tsuchiya, T., Tabata, O., & Kamei, K.-I. (2023) · Communications Biology · doi:10.1038/s42003-023-04710-8 · Cited by 98
Stem cell sources for vascular tissue engineering and regeneration
Bajpai, V. K., & Andreadis, S. T. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0264 · Cited by 95
“These iPSCs exhibited molecular signatures similar to ESC and successfully produced chimeric mice, indicating germ-line transmission.215 In addition, the Thomson group demonstrated that two of the transcription factors (KLF4 and cMyc) which were used for iPSCs generation could be replaced by NANOG and LIN28.”
BackgroundKozlov, A. M., Lone, A., Betts, D. H., & Cumming, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65193-9 · Cited by 94
Panicker, L. M., Miller, D., Awad, O., Bose, V., Lun, Y., Park, T. S., Zambidis, E. T., Sgambato, J. A., & Feldman, R. A. (2014) · Stem Cells · doi:10.1002/stem.1732 · Cited by 92
Sussman, R. T., Stanek, T. J., Esteso, P., Gearhart, J. D., Knudsen, K. E., & McMahon, S. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469783 · Cited by 91
Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
Wang, J., Wang, L., Yang, M., Zhu, Y., Tomsia, A., & Mao, C. (2014) · Nano Letters · doi:10.1021/nl504358j · Cited by 90
Gaj, T., Staahl, B. T., Rodrigues, G. M. C., Limsirichai, P., Ekman, F. K., Doudna, J. A., & Schaffer, D. V. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx154 · Cited by 89
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
“Additionally, these cells have provided a robust cellular platform for the scientific community and, most importantly, have opened up the door to the development of iPSCs. iPSCs, the “artificial” counterpart of ESCs, are generated from adult somatic cells, such as skin fibroblasts, skin keratinocytes, peripheral blood…”
BackgroundJedrzejczak-Silicka, M. (2017) · New Insights into Cell Culture Technology · doi:10.5772/66905 · Cited by 87
Non-muscle myosin II regulates survival threshold of pluripotent stem cells
Walker, A., Su, H., Conti, M. A., Harb, N., Adelstein, R. S., & Sato, N. (2010) · Nature Communications · doi:10.1038/ncomms1074 · Cited by 87
The Role of Hypoxia in Stem Cell Potency and Differentiation
Hawkins, K. E., Sharp, T. V., & McKay, T. R. (2013) · Regenerative Medicine · doi:10.2217/rme.13.71 · Cited by 87
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery
Braam, S. R., Passier, R., & Mummery, C. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.001 · Cited by 86
Palmer, N. P., Schmid, P. R., Berger, B., & Kohane, I. S. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r71 · Cited by 86
“While some have been observed to express a subset of the embryonic stem cell-associated genes (POU5F1, NANOG), the degree to which these trends may be broadly apparent is unknown [20].”
BackgroundAssou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 81
Skeletal Muscle Degenerative Diseases and Strategies for Therapeutic Muscle Repair
Tabebordbar, M., Wang, E. T., & Wagers, A. J. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132450 · Cited by 79
“ZFN: zinc-finger nuclease can be propagated indefinitely in culture and can, in principle, differentiate into any cell type in the body (201, 202).”
BackgroundMECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Rastegar, M., Hotta, A., Pasceri, P., Makarem, M., Cheung, A. Y. L., Elliott, S., Park, K. J., Adachi, M., Jones, F. S., Clarke, I. D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006810 · Cited by 79
“To this end, recent advances deriving induced pluripotent stem (iPS) cells from human fibroblasts [39–41] now permit generation of patient-specific iPS cells [42–44].”
BackgroundRoux, A. E., Zhang, C., Paw, J., Zavala-Solorio, J., Malahias, E., Vijay, T., Kolumam, G., Kenyon, C., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 78
Developing cellular therapies for retinal degenerative diseases
Bharti, K., Rao, M., Hull, S. C., Stroncek, D., Brooks, B. P., Feigal, E., van Meurs, J. C., Huang, C. A., & Miller, S. S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13481 · Cited by 77
Poleganov, M. A., Eminli, S., Beissert, T., Herz, S., Moon, J.-I., Goldmann, J., Beyer, A., Heck, R., Burkhart, I., Barea Roldan, D., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.045 · Cited by 77
Calcium signalling of human pluripotent stem cell-derived cardiomyocytes
Li, S., Chen, G., & Li, R. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256495 · Cited by 76
“Forced expression of four pluripotency genes, Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi & Yamanaka, 2006; Meissner et al. 2007; Takahashi et al. 2007), or Lin28 (Yu et al. 2007) suffices to reprogramme fibroblasts into iPSCs.”
BackgroundCereso, N., Pequignot, M. O., Robert, L., Becker, F., De Luca, V., Nabholz, N., Rigau, V., De Vos, J., Hamel, C. P., & Kalatzis, V. (2014) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2014.11 · Cited by 72
Stem cell secretome, regeneration, and clinical translation: a narrative review
Gwam, C., Mohammed, N., & Ma, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5030 · Cited by 72
“Alternatively, IPSCs are derived from adult somatic cells and are reprogrammed into a pluripotent state by induced expression of certain transcription factors (9-12).”
BackgroundJiang, Y., Cowley, S. A., Siler, U., Melguizo, D., Tilgner, K., Browne, C., Dewilton, A., Przyborski, S., Saretzki, G., James, W. S., et al. (2012) · Stem Cells · doi:10.1002/stem.1053 · Cited by 71
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
Gurumoorthy, N., Nordin, F., Tye, G. J., Wan Kamarul Zaman, W. S., & Ng, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10010107 · Cited by 69
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Cipriano, A., Moqri, M., Maybury-Lewis, S. Y., Rogers-Hammond, R., de Jong, T. A., Parker, A., Rasouli, S., Schöler, H. R., Sinclair, D. A., & Sebastiano, V. (2023) · Nature Aging · doi:10.1038/s43587-023-00539-2 · Cited by 66
“Shortly after, the same factors were used to induce pluripotency in various mouse and human somatic cell types 29,30 .”
Linta, L., Stockmann, M., Kleinhans, K. N., Böckers, A., Storch, A., Zaehres, H., Lin, Q., Barbi, G., Böckers, T. M., Kleger, A., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0026 · Cited by 65
“Fifty nanograms of converted DNA was used as a template for conventional nested PCRs amplifying regions of the OCT4 and NANOG promoters using primers described earlier [27].”
InfluentialVascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice
Sakai, Y., Yamanouchi, K., Ohashi, K., Koike, M., Utoh, R., Hasegawa, H., Muraoka, I., Suematsu, T., Soyama, A., Hidaka, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.046 · Cited by 65
Azuma, K., & Yamanaka, S. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.01.009 · Cited by 63
“Induced pluripotent stem cells (iPSCs) were firstly made from mice in 2006 [1] and from humans in 2007 [2,3].”
BackgroundDeveloping defined substrates for stem cell culture and differentiation
Hagbard, L., Cameron, K., August, P., Penton, C., Parmar, M., Hay, D. C., & Kallur, T. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0230 · Cited by 62
“Following the derivation of human embryonic stem cells (hESCs) in 1998 [1], and with the development of human induced pluripotent stem cells (hiPSCs) in 2007 [2,3], stem cell research is rapidly progressing from pre-clinical studies to the clinical arena with the first human trials having already begun.”
BackgroundFunctional Interactions Between microRNAs and RNA Binding Proteins
Jiang, P., & Coller, H. (2012) · MicroRNA e · doi:10.2174/2211536611201010070 · Cited by 62
“Further, Lin28 is one of the proteins that, in concert with others, can contribute to the creation of induced pluripotent stem cells [100].”
Background3′ RNA Uridylation in Epitranscriptomics, Gene Regulation, and Disease
Menezes, M. R., Balzeau, J., & Hagan, J. P. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00061 · Cited by 62
“The significance of the LIN28/let-7 pathway is further highlighted by the fact that LIN28A is a Thomson reprogramming factor whose expression on its own is necessary and sufficient to make induced pluripotent stem cells (Yu et al., 2007; Buganim et al., 2012).”
BackgroundHuman induced pluripotent stem cell-derived beating cardiac tissues on paper
Wang, L., Xu, C., Zhu, Y., Yu, Y., Sun, N., Zhang, X., Feng, K., & Qin, J. (2015) · Lab on a Chip · doi:10.1039/c5lc00919g · Cited by 61
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
“This results in the integration of reprogramming genes into the genome and subsequent reactivation of the endogenous counterparts [11, 14].”
BackgroundDesign, Assembly, Production, and Transfection of Synthetic Modified mRNA
Oh, S., & Kessler, J. A. (2018) · Methods · doi:10.1016/j.ymeth.2017.10.008 · Cited by 58
Brydon, E. M., Bronstein, R., Buskin, A., Lako, M., Pierce, E. A., & Fernandez-Godino, R. (2019) · doi:10.1101/729160 · Cited by 56
Gliotoxin penetrates and impairs the integrity of the human blood-brain barrier in vitro
Patel, R., Hossain, M. A., German, N., & Al-Ahmad, A. J. (2018) · Mycotoxin Research · doi:10.1007/s12550-018-0320-7 · Cited by 56
Lian, Q., Chow, Y., Esteban, M., Pei, D., & Tse, H.-F. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0269 · Cited by 55
Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5356 · Cited by 54
“Transcription factors such as POU5F1, SOX2, LIN28A, NANOG and MYC have been associated with the reprogramming of human somatic cells to pluripotent stem cells [19], as well as cancer cells with stemness properties.”
BackgroundSugiura, T., Hibino, N., Breuer, C. K., & Shinoka, T. (2016) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-016-0559-z · Cited by 53
“Induced pluripotent stem (iPS) cells were first generated by nuclear reprogramming of mouse fibroblasts in 2006 [3], and human iPS (hiPS) cells were established in 2007 [4, 5].”
BackgroundKhan, M., Narayanan, K., Lu, H., Choo, Y., Du, C., Wiradharma, N., Yang, Y.-Y., & Wan, A. C. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.072 · Cited by 50
“The forced expression of Oct4, Klf4, Sox2 and c-Myc (Yamanaka factors, [3]) or Oct4, Sox2, Nanog and Lin28 (Thomson factors, [4]) were shown to induce the transformation of adult fibroblasts to iPSCs.”
BackgroundYuan, X., Hierlemann, A., & Frey, U. (2021) · IEEE Journal of Solid-State Circuits · doi:10.1109/jssc.2021.3066043 · Cited by 50
“In addition, recent advances in inducedpluripotent-stem-cell (iPSC) technology provide a promising approach to study neurological disorders with human in vitro systems [1]–[3].”
BackgroundBiological effects of culture substrates on human pluripotent stem cells
Hayashi, Y., & Furue, M. K. (2016) · Stem Cells International · doi:10.1155/2016/5380560 · Cited by 50
“(hESCs) were derived from the inner cell mass (ICM) of the blastocyst [1], and human induced pluripotent stem cells (hiPSCs) were generated by introducing key transcription factors into somatic cells [2, 3].”
VanderWall, K. B., Vij, R., Ohlemacher, S. K., Sridhar, A., Fligor, C. M., Feder, E. M., Edler, M. C., Baucum, A. J., Cummins, T. R., & Meyer, J. S. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.010 · Cited by 46
Nucleosome binding by the pioneer transcription factor OCT4
Echigoya, K., Koyama, M., Negishi, L., Takizawa, Y., Mizukami, Y., Shimabayashi, H., Kuroda, A., & Kurumizaka, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-68850-1 · Cited by 47
Crombie, D. E., Daniszewski, M., Liang, H. H., Kulkarni, T., Li, F., Lidgerwood, G. E., Conquest, A., Hernández, D., Hung, S. S., Gill, K. P., et al. (2017) · SLAS Discovery · doi:10.1177/2472555217696797 · Cited by 46
“As illustrated in Figure 1, on the workbench, from left to right, are a cabinet with medium bottle and pump (1) which can deliver medium to a LiHa medium refill trough contained within a Torrey Pines heater; three carriers for up to 24 × 50 mL Falcon tubes (2), a LiHa wash station (3), a carrier for 5 mL DiTis (4), a…”
BackgroundPark, T. S., Huo, J. S., Peters, A., Talbot, C. C., Verma, K., Zimmerlin, L., Kaplan, I. M., & Zambidis, E. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042838 · Cited by 45
“pluripotency. We determined the expression signatures of these non-integrated hiPSC clones with Illumina microarrays, and also included previously described lentiviral hiPSC lines IMR90-1 and IMR90-2”
MethodZhang, H., Xue, Y., Pan, T., Zhu, X., Chong, H., Xu, C., Fan, F., Cao, H., Zhang, B., Pan, J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056264 · Cited by 44
OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts
Narayan, S., Bryant, G., Shah, S., Berrozpe, G., & Ptashne, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.071 · Cited by 43
“Others have reported (and we have observed – not shown) that many transcription factors expressed in fibroblasts are turned off and other new transcription factors are produced in iPS cells (Yu et al., 2007).”
BackgroundInfluentialPluripotent Stem Cell Platforms for Drug Discovery
Chen, K. G., Mallon, B. S., Park, K., Robey, P. G., McKay, R. D. G., Gottesman, M. M., & Zheng, W. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.009 · Cited by 43
End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
Pandey, P. R., Tomney, A., Woon, M. T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., & Friedrich Ben-Nun, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010089 · Cited by 42
“Successful generation of human-induced pluripotent stem cells (hiPSCs) by somatic cell reprogramming has opened new avenues in regenerative medicine, disease modeling and drug development [1,2].”
BackgroundOvadia, E. M., Colby, D. W., & Kloxin, A. M. (2018) · Biomaterials Science · doi:10.1039/c8bm00099a · Cited by 40
Applications of induced pluripotent stem cells in studying the neurodegenerative diseases
Wan, W., Cao, L., Kalionis, B., Xia, S., & Tai, X. (2015) · Stem Cells International · doi:10.1155/2015/382530 · Cited by 40
“also generated human iPSCs, in which the factors Oct4, Sox2, Nanog, and LIN28 and a lentiviral system were used to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of ECSs [7].”
BackgroundMethodHeterochromatin loosening by the Oct4 linker region facilitates Klf4 binding and iPSC reprogramming
Chen, K., Long, Q., Xing, G., Wang, T., Wu, Y., Li, L., Qi, J., Zhou, Y., Ma, B., Schöler, H. R., et al. (2020) · The EMBO Journal · doi:10.15252/embj.201899165 · Cited by 40
“Pluripotent stem cells (PSCs) can be derived from the inner cell mass of blastocysts (Evans & Kaufman, 1981) or induced from somatic cells by defined factors (Takahashi & Yamanaka, 2006; Yu et al , 2007).”
Self-citationThe NuRD complex cooperates with SALL4 to orchestrate reprogramming
Wang, B., Li, C., Ming, J., Wu, L., Fang, S., Huang, Y., Lin, L., Liu, H., Kuang, J., Zhao, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38543-0 · Cited by 39
Genome engineering of stem cell organoids for disease modeling
Sun, Y., & Ding, Q. (2017) · Protein & Cell · doi:10.1007/s13238-016-0368-0 · Cited by 39
Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders
Schadt, E. E., Buchanan, S., Brennand, K. J., & Merchant, K. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00252 · Cited by 39
“…routinely generated from patient skin or blood cells, owing to the relative ease of tissue access, and are believed to be capable of differentiating into every cell type found in the adult (Maherali et al., 2007; Meissner et al., 2007; Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007).”
BackgroundWang, L., Su, Y., Huang, C., Yin, Y., Chu, A., Knupp, A., & Tang, Y. (2019) · Biology Open · doi:10.1242/bio.047225 · Cited by 39
The emerging functions of the p53-miRNA network in stem cell biology
Lin, C.-P., Choi, Y. J., Hicks, G. G., & He, L. (2012) · Cell Cycle · doi:10.4161/cc.20207 · Cited by 38
Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143238 · Cited by 38
“Reprogramming of human fibroblasts was carried out using two more genes (c-MYC and KLF4) in addition to four genes (OCT4, SOX2, NANOG and LIN28) described originally [36].”
MethodYoshioka, N., & Dowdy, S. F. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182018 · Cited by 36
Comparison of Cardiomyogenic Potential among Human ESC and iPSC Lines
Sepac, A., Si-Tayeb, K., Sedlic, F., Barrett, S., Canfield, S., Duncan, S. A., Bosnjak, Z. J., & Lough, J. W. (2012) · Cell Transplantation · doi:10.3727/096368912x653165 · Cited by 36
“The first two of these issues may have been recently resolved by the ability to induce pluripotent stem cells (hiPSCs) from human dermal fibroblasts via transduction of pluripotency factors encoded in retroviral vectors (13,15).”
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.